← All trials
NCT05181462
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 11, 2022
- Primary completion
- Aug 31, 2024
- Completion date
- Aug 31, 2026
- First posted
- Jan 6, 2022
- Last posted
- Mar 3, 2022
- Enrollment
- 116
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Cantargia ABLead sponsor
- Cantargia ABStudy director
- University of NavarraStudy director
- Spanish Breast Cancer Research GroupCollaborator
- University of NavarraOfficial
- Cantargia ABOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.